Abstract: An aqueous cleaning composition, which may be suitable for use in cleaning hard surfaces, is described. The aqueous cleaning composition includes an ionic liquid solvent, an amino alcohol, and a substantial amount of water. The cleaning compositions may also include a disinfecting quaternary surfactant, a nonionic surfactant, such as an ethoxylated alcohol and/or alkyl polyglycoside, and/or a chelating agent, such as an aminopolycarboxylate chelating agent.

Abstract: A detergent composition having a) from about 1% to about 60%, by weight of the composition, of a surfactant system wherein the surfactant system includes: i) at least 35%, by weight of the surfactant system, of nonionic surfactant and ii) from 5% to about 20%, by weight of the surfactant system, of amine oxide. The detergent composition having greater than 3% of fatty acid.

Abstract: Compositions and methods of this disclosure include liquid cosmetic compositions, for example, an eyeliner, that is applied to the surface of a user (e.g., a person), the surface including, for example, an eyelid, the liquid cosmetic product including a ferromagnetic component that is capable of being attracted by and attached to a magnet, the magnet part of a false eyelash.

Abstract: A skincare composition is provided, which comprises at least one clay, at least one first binding agent; and at least one second binding agent. The composition is to be used in a peristomal environment, and provides neutralization of stomal output.

Abstract: The disclosure relates to compositions and methods for improving the appearance of the skin. Compositions comprise at least one thermoplastic elastomer, at least one adhesive polymer, and at least one filler. Methods comprise applying the compositions to the skin to tighten the skin or hide skin imperfections by forming a film on the skin.

Abstract: Described herein are personal care compositions comprising a stability control system comprising a non-ionic opacifier, and a cationic polymer. Methods of making and using the compositions are also described.

Abstract: The present invention describes novel plant derived elastin-like peptides and peptidomimetics that may serve as functional ligands for elastin receptors and stimulate elastogenesis. The novel plant derived peptides provide an alternative (non-animal derived) source of GXXPG (SEQ ID NO. 2) containing peptides. The present invention also describes therapeutic compositions containing novel plant derived peptides or peptidomimetics useful in stimulating elastogenensis and capillary dilatation. The therapeutic compositions of the present invention that comprise novel plant derived peptides or peptidomimetics may be combined with other therapeutic agents.

Abstract: The present specification discloses a composition comprising, consisting essentially of, or consisting of hypochlorous acid or free available chlorine and one or more disinfectants, a composition comprising, consisting essentially of, or consisting of hypochlorous acid or free available chlorine, one or more disinfectants and one or more surfactants, a composition comprising, consisting essentially of, or consisting of hypochlorous acid or free available chlorine and one or more surfactants, a composition comprising, consisting essentially of, or consisting of one or more guanide-containing compound and one or more alcohols, kits comprising, consisting essentially of, or consisting of a disclosed composition, as well as methods and uses to clean, disinfect and/or sterilize a device using such compositions, methods and uses to clean, disinfect and/or sterilize a surface area using such compositions, methods and uses to clean, disinfect and/or sterilize a microbial infection in an individual using such composit

Abstract: A sealing system that includes a switchable drape is presented. The drape provides enhanced sealing by using a high-strength adhesive. In one instance, the switchable drape has a plurality of perforations through which a switching solution may be delivered to the high-strength adhesive. The switching solution causes the high-strength adhesive to become less adhesive so that the switchable drape may be removed more easily. Other systems, methods, and drapes are presented.

Abstract: A topical pharmaceutical or cosmetic composition for treatment of irritation of mucous cells such as mucosal cells of the eye, nose, and vagina is disclosed. The composition comprises an aqueous solution of at least one polyol selected from the group consisting of xylitol, myoinositol and mannitol and at least one substance selected from the group consisting of glycerol and urea. The composition contains less than 0.01% inorganic salt and is free of any oil-in-water or wax-in-water emulsion. In particularly preferred embodiments, the composition comprises an aqueous solution containing 1.5-5% (w/v) xylitol and 0.9-2.0% (w/v) glycerol.

Abstract: A production method of a liquid high-purity polyhydric alcohol derivative-modified silicone or a composition thereof is disclosed. The method comprises: a capturing step 1) of bringing into an impurity-containing composition containing a liquid polyhydric alcohol derivative-modified silicone and hydrophilic impurities originating from a polyhydric alcohol derivative, the polyhydric alcohol derivative being a hydrophilic modifier of the polyhydric alcohol derivative-modified silicone, into contact with solid particles capable of capturing the hydrophilic impurities, and then capturing the hydrophilic impurities with the solid particles; and a separating step 2) of separating the polyhydric alcohol derivative-modified silicone and the solid particles. The method is useful for production of the liquid high-purity polyhydric alcohol derivative-modified silicone and the composition thereof on a commercial scale.

Abstract: A coating composition includes water, a plurality of flakes having a maximum dimension less than 0.05 inches, a plurality of inorganic fibers, a thixotropic suspending agent that is insoluble in water, and a resin. Decorative coating on a concrete substrate is also provided.

Abstract: The present disclosure relates to topical formulations comprising purified water, milk protein fluid and thickener, in particular a hydrogel and a lotion, and their use in treatment of radiation dermatitis, in particular in a two-step process for the treatment of radiation dermatitis.

Abstract: The present invention provides a cleansing composition comprising the following components (A), (B), and (C): (A) 0.001 to 5% by mass of a polymer selected from the group consisting of (A-1), (A-2), and (A-3): (A-1) an acrylic copolymer comprising 10 mol % or more of a monomer selected from the group consisting of an acrylic acid alkyl ester and a methacrylic acid alkyl ester, as represented by mol % based on the total monomers; (A-2) a polysaccharide derivative having a polyoxyalkylene chain having an average molecular weight of 300 to 100,000; and (A-3) a polyether polycarbonate; (B) 1 to 50% by mass of one or two or more oil agents selected from the group consisting of (b1) and (b2): (b1) an ether oil and (b2) a hydrocarbon oil having a viscosity of 18 mPa·s or lower at 30° C.; and (C) water, and comprising (D) no nonionic surfactant having HLB of 8 or more or less than 5% by mass of the nonionic surfactant.

Abstract: Provided is a skin cleansing composition comprising the following components (A), (B), (C), (D), and (E): (A) 0.1 to 25 mass % of an ether oil which is in a liquid state at 25° C., (B) 0.003 to 1 mass % of a water-soluble polymer comprising acrylic acid or methacrylic acid as a constitutional unit, (C) 1 to 30 mass % of a hydrocarbon oil having a viscosity of 15 mPa·s or lower at 30° C., (D) 60 to 95 mass % of water, and (E) 0.49 mass % or less of a nonionic surfactant having an HLB of larger than 9, wherein the mass ratio of the component (B) to the component (A), (B)/(A) is from 0.0001 to 0.1, and the mass ratio between the component (A) and the component (C), (A)/((A)+(C)) is from 0.05 to 0.9.

Abstract: The invention relates to a composition in the form of an oil-in-water emulsion and its use that contains in a physiologically acceptable medium, i) at least 0.005% by weight, preferably at least 0.01% by weight, relative to the total weight of the composition, of at least one inulin modified with hydrophobic chains, and ii) at least 0.01% by weight, preferably at least 0.05% by weight, of active substance relative to the total weight of the composition, of at least one hydrophilic acrylic polymer selected from the at least partially neutralized, crosslinked acrylic homopolymers or copolymers, the polyacrylamidomethylpropanesulphonic acid (AMPS) homopolymers and mixtures thereof.

Abstract: A composition comprising: a benefit agent; at least one polymer including a polycaprolactone polymer; at least one lower alcohol; and at least one co-solvent; and a method for enhancing topical delivery of a benefit agent is disclosed.

Abstract: A skin composition includes between 5% and 95% of polyethylene glycol and between 5% and 95% of glycereth. The composition is a gel that is formulated for application to an individual's skin.

Abstract: Biocompatible adhesive materials, such as for use with biological tissues and/or medical implants, are provided, as well as methods and kits for making and using the biocompatible adhesive materials. The biocompatible adhesive materials include a dendrimer component and a polymer component, and may be tailored for specific tissue types and conditions.

Abstract: Biocompatible hydrogels made from cross-linked catechol-borate ester polymers are disclosed, along with methods of synthesizing and using such hydrogels. The hydrogels of the present invention are prepared by boronic acid-catechol complexation between catechol-containing macromonomers and boronic acid-containing cross-linkers. The resulting hydrogels are pH-responsive and self-healing, and can be used in a number of different biomedical applications, including in surgical implants, in surgical adhesives, and in drug delivery systems is data provides further evidence of the viability of using the disclosed hydrogels for in vivo in biomedical applications.

Abstract: The invention provides compositions, methods and kits for the removal of harmful or irritating substances from bodily surfaces. Kits may include a composition containing capsaicin and a capsaicin-cleansing composition, e.g., a composition in which capsaicin is soluble.

Abstract: A water-in-silicone oil (W/S) macroemulsion cosmetic composition of waterdrop quick break type is provided. The silicone oil phase part (S) contains a partly crosslinked emulsifiable silicone elastomer, a partly crosslinked non-emulsifiable silicone elastomer, and silicone oil, and the aqueous phase part (W) contains 1,3-butylene glycol and a lower alcohol, and also, at least one member selected from the group consisting of organic acid salts, inorganic salts, and polyhydric alcohols excluding glycerin and 1,3-butylene glycol as a freeze stabilizer at a predetermined composition. The cosmetic composition instantaneously releases water upon application on the skin. The cosmetic composition is stable at the extremely low temperature of ?20° C., and it retains its dispersion stability even after repeated freezing and thawing, and accordingly, it can be used in a variety of cosmetic product.

Abstract: The invention relates to a novel solubilized small molecule topical formulation for the transdermal delivery of small molecule agents comprising: a small molecule agent, one or more micelle forming compounds, one or more skin penetration enhancers, a surfactant, and one or more solvents, wherein the small molecule agent is solubilized in the solvent. The invention further relates to the use of the topical formulation as well as the process for making the topical formulation.

Abstract: The invention relates to a novel solubilized benzoyl peroxide topical formulation for the treatment of acne comprising: benzoyl peroxide, one or more micelle forming compounds, one or more skin penetration enhancers, a surfactant, and one or more solvents, wherein the benzoyl peroxide is solubilized in the solvent. The invention further relates to the use of the topical formulation as well as the process for making the topical formulation.

Abstract: A skin antisepsis composition comprising a comprising a (C1-4)alcohol and water in a ratio of at least 60:40, a hydroxycarboxylic acid, a cationic film-forming polymer, and at least one antimicrobial agent; and methods of using the composition are provided.

Abstract: The present invention relates to a novel dermal filler composition and a method for preparing the same. Even though the composition of the present invention comprises, as a main component, only cross-linked dextran having the molecular weight of 30,000 to 100,000, the composition can rapidly augment a detective area of the skin and maintain softness to the touch even, the composition eliminates the necessity of a pretreatment, such as an allergy test, which might otherwise be required prior to injection, is inexpensive, and is not easily decomposed or absorbed in vivo, thereby stably maintaining the tissue-volume augmentation effects after injection over a long period of time.

Abstract: The present invention relates to a make-up cosmetic composition containing MQ silicone resin and propyl silsesquioxane resin, and, more specifically, relates to a make-up cosmetic composition which contains MQ silicone resin and propyl silsesquioxane resin, gives an outstanding moisturising impression and is free from any pulling phenomenon.

Abstract: A protective coating solution, liquid, gel, or film and a method of using such a material to provide a sterile covering for fingers, hands, arms or other selected skin surface for use as a glove substitute.

Abstract: Disclosed are compositions and methods for their use that can be used individually or in combination. The compositions have the ability to treat a wide range of skin and skin conditions, and particularly men's skin.

Abstract: A method for manufacturing a cosmetic cleaning agent includes the steps of a) providing an aqueous dispersion that includes at least one inorganic pigment and/or at least one opacifier and/or luster agent; b) providing a preparation that includes at least one acrylate homo- or copolymer; c) mixing the aqueous dispersion from method step a) with the preparation from method step b); d) providing an O/W emulsion; e) mixing the O/W emulsion from method step d) with the mixture from method step c); f) providing a cosmetically acceptable carrier that includes at least one surfactant; g) mixing the cosmetically acceptable carrier from method step f) with the mixture from method step e).

Abstract: The present invention provides a cosmetic composition comprising, in a cosmetically acceptable organic liquid medium, at least one film-forming ethylenic linear block polymer, and another film former. The film former may be soluble or dispersible in the said organic liquid medium. The composition may include an aqueous phase, in which case the film former may be soluble or dispersible in the aqueous phase. The invention further provides for the use of the combination of such a block polymer and a film former for enhancing the staying power of the said composition on the keratin materials.

Abstract: The present invention is an anhydrous cosmetic composition for making up and/or caring for the skin and/or lips, which is liquid at 20° C., comprising, in a physiologically acceptable medium, at least one fatty phase comprising:—at least one organopolysiloxane elastomer powder coated with silicone resin,—at least one organopolysiloxane elastomer conveyed in a first oil,—at least one wax, and—at least one second oil,—the said organopolysiloxane elastomer and the organopolysiloxane elastomer powder coated with a silicone resin being present in a ratio by weight on a dry basis of organopolysiloxane elastomer conveyed in an oil/organopolysiloxane elastomer powder coated with a silicone resin of greater than 2 and preferably of greater than 2.5.

Abstract: The present invention relates to a protective agent suitable to protect the human skin against toxic materials, particularly against chemicals with nucleophilic sites. The active moiety is a polyanhydride derivative. The active transdermal retardant offers a barrier property and chemically and/or physically reacts with harmful chemicals to decrease percutaneous absorption. In the preferred embodiments, polyanhydride in its low molecular weight form reduced flux of nicotine and nitrofurazone significantly. Additionally, polyanhydride in its high molecular weight form prevented nicotine absorption and decreased nitrofurazone permeation dramatically. Moreover, the polyanhydride in its high molecular weight form reduced nitroglycerin flux to a lesser extent.

Abstract: A method for producing an aqueous cosmetic composition containing the following components (A), (B) and (C): (A) a primary amine, a secondary amine, a tertiary amine or a quaternary amine having 12 to 60 carbons in total, (B) an anionic polymer having a carboxyl group, and (C) water, and, containing: a liquid crystal constituted by the components (A), (B) and (C); obtained by mixing the components (A), (B) and (C); heating the mixture to a temperature equal to or higher than the melting point of the component (A) to homogenize the mixture; and neutralizing the component (B) with the component (A) to form a salt.

Abstract: The invention relates to an epilatory mixture comprising a fructan, preferably inulin. Furthermore, an epilatory composition is disclosed comprising said epilatory effective mixture. Also a method of use of said epilatory composition of the invention for the removal of unwanted hair from the skin is disclosed, as well as a method of use of said composition for carrying out an epilatory treatment which can be carried out by a professional person as well as by a non-professional person.

Abstract: Disclosed is a topical skin care composition and corresponding methods for its use comprising water, a cationic surfactant, an occlusive skin conditioning agent, a humectant skin conditioning agent, and a silicone containing compound. The composition is dermatologically acceptable and is capable of moisturizing skin for at least twelve hours after topical application to skin even after multiple washings of the skin.

Abstract: Compositions and methods are provided that are useful for the delivery, including transdermal delivery, of biologically active agents, such as non-protein non-nucleotide therapeutics and protein-based therapeutics excluding insulin, botulinum toxins, antibody fragments, and VEGF. The compositions and methods are particularly useful for topical delivery of antifungal agents and antigenic agents suitable for immunization. Alternately, the compositions can be prepared with components useful for targeting the delivery of the compositions as well as imaging components.

Abstract: The present invention provides a hydrocolloid composition which, based on 100% by weight of the hydrocolloid composition, comprises: 10-90%) by weight of a polyisobutylene tackifier; 5-55% by weight of a hydrophilic absorbing substance; and 0.1-20% by weight of a functional ingredient. The invention further provides an article containing the hydrocolloid composition.

Abstract: Peptides of general formula (I): R1-Wn-Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp-Zs-R2 their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, their preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases that are a consequence of muscle contraction.

Abstract: The present invention relates to aqueous polyurethane dispersions for sealing teats of animal mammary glands.

Abstract: The invention relates to aqueous suspension of composite silicone powder, W/O emulsion and cosmetics, providing an aqueous suspension of composite silicone powder comprising: (A) a composite cured silicone powder comprising (a) a cured silicone powder, (b) an inorganic fine powder coated on the surface of said cured silicone powder, (c) at least one hydrophilic compound coating on the surface of component (a) and/or component (b); and (B) water, wherein the viscosity of said aqueous suspension is in the range of 25 to 500 mPa·s at 25 degrees C.

Abstract: An anionic polyelectrolyte resulting from the polymerization, for 100% by mass of: a) a mass ratio ?70% and ?98.5% of monomeric units from a monomer with a strong acid function; b) a mass ratio ?0.5% and ?10%,—either of a monomer of formula (1a) : R—(CH2)3-Si(CH2)2-[0-Si(CH3)2-]nO—Si(CH3)2—(CH2)3—R (1a), wherein R represents the monovalent radical: -(0-CH2-CH2-)x[0-CH2—CH(CH3)-]yO—C(?0)-CH?CH2;—or (Ib): Si(CH3)3-[0-Si(CH3)2-]m[0-Si(CH3)[(CH2)3—R]—]pO—Si(CH2)3 (Ib), c) a mass ratio ?1% and ?20% of a monomer of formula (II) : CH2?CH(R1)-C(?0)-0-(CH2)n—CF3 (II), formula (I) wherein radical Ri represents a hydrogen atom or a methyl radical, and n is equal to 1, 2 or 3; d) optionally a mass ratio >0% and ?5% of monomeric units from a monomer of formula (III): R2—C(?0)-0-[(CH2—CH(R4)-0]m-R3 (III), e) optionally a mass ratio >0% and ?5% of a cross-linking monomer, method for its preparation and use as a thickener in topical compositions.

Abstract: A transfer-resistant, single phase aqueous cosmetic compositions are provided. The compositions consist essentially of a water-soluble, film-forming acrylates copolymer and a water-soluble plasticizer for the copolymer. The compositions contain no oils, waxes, surfactants or emulsifiers, are water- and oil-resistant upon drying on the skin, and exhibit high gloss and long-wear and transfer-resistant properties. Compositions containing pigment also demonstrate high color intensity. The compositions are useful as eyeliner, mascara, lipgloss, lipliner, and other cosmetic products.

Abstract: The invention relates to siloxane polymers comprising a central polysiloxane polymer block B with organofunctional radicals bonded terminally or laterally to the polymer block and based on IPDI and UV/Vis chromophores or derivatives, in particular UV chromophores, which are covalently bonded via a hydrophobic or hydrophilic linker group Q1?, Q2?, and compositions comprising these siloxanes. Also disclosed are processes for their preparation and their use.

Abstract: A polymer system useful for in vivo delivery of a therapeutic agent is provided. The polymer system comprises a biocompatible biodegradable polymeric backbone that is capable of a reversible stimuli-induced transition from liquid to gel.

Abstract: The present invention relates to a hyaluronidase inhibitor containing poly-gamma-glutamic acid (PGA) as an active ingredient, a composition for maintaining skin elasticity and a composition for improving allergy, wherein each of the compositions contains PGA as an active ingredient. The inventive compositions containing PGA are effective in maintaining skin moisturization and skin elasticity by effectively inhibiting the activity of hyaluronidase which is an enzyme that degrades hyaluronic acid present in the skin dermis. Also, the compositions can relieve allergic symptoms by inhibiting the permeability of inflammatory cells.

Abstract: A method of in-situ adhering comprising providing pre-gel that comprises a mixture of at least one phenol-based compound and at least one water miscible polymer selected from at least one of a naturally existing form of a carbohydrate, a synthetically prepared form of carbohydrate and a salt of an anionic polysaccharide; spreading a layer of the pre-gel onto a first surface; adding a solid support, comprising at least one cross linking agent capable of interacting with the water miscible polymer to the pre-gel; and allowing the pre-gel to cure and adhere onto the first surface.

Abstract: A cosmetic treatment method, and a device therefor, are provided that allow for cosmetic treatment of cosmetic disorders, caused by chronological age, environmental factors, changes in physiological functions of skin, such as psoriasis, dermatitis, acne, cellulites, and viral and/or bacteriological attacks. The device comprises a nitric oxide (NO) eluting polymer arranged to contact the area to be cosmetically treated, such that a cosmetic dose of nitric oxide is eluted from said nitric oxide eluting polymer to said area. The nitric oxide (NO) eluting polymer is integrated with a carrier material, such that said carrier material, in use, regulates and controls the elution of said cosmetic dosage of nitric oxide (NO). Furthermore, a manufacturing method for said device is provided.

Abstract: A shampoo composition with improved in use hair feel, comprising associative thickeners and liquid crystals formed from anionic surfactants and polyDADMAC and wherein the liquid crystals have a particle size greater than about 1 micrometer.

Abstract: Disclosed is a medicinal cream that includes flisidic acid which is made in situ under an oxygen-free environment using sodium fusidate. The fusidic acid is made by dissolving the sodium fusidate in a co-solvent under inert gas purging and under vacuum, and converting the sodium fusidate to fusidic acid in situ by adding an acid under stirring, The disclosed medicinal cream also includes a biopolymer and a cream base comprising at least one of each of a primary and secondary emulsifier, a waxy material, and water.